COVID-19

Introduction and Pathophysiology of COVID-19

COVID-19 is caused by the SARS-CoV-2 virus, a member of the coronavirus family. The virus spreads primarily through respiratory droplets when an infected person coughs, sneezes, or talks. Once inside the human body, the spike protein of SARS-CoV-2 binds specifically to ACE2 receptors, which are abundant on the surface of epithelial cells in the respiratory tract, lungs, and other organs.

Following viral entry, intracellular replication triggers local immune responses. In severe cases, this immune response becomes dysregulated, leading to a massive release of pro-inflammatory cytokines known as a cytokine storm. This hyperinflammatory state causes diffuse alveolar damage, pulmonary edema, and can rapidly progress to Acute Respiratory Distress Syndrome (ARDS) and multi-organ failure.

Modes of Transmission and Infection Control Precautions

SARS-CoV-2 transmission occurs predominantly via the airborne route through exposure to respiratory fluids carrying infectious virus. These range from larger droplets to smaller aerosols that can remain suspended in indoor air. Contact with contaminated surfaces is a less common secondary route.

To prevent nosocomial spread in healthcare settings, nurses must strictly adhere to infection control measures:

• Standard Precautions: Consistent hand hygiene and environmental disinfection for all patient encounters.
• Contact and Droplet Precautions: Use of medical masks, gowns, gloves, and eye protection during routine care.
• Airborne Precautions: Mandatory use of fit-tested N95 respirators or higher-level masks during aerosol-generating procedures such as intubation, suctioning, or nebulizer therapy.

Clinical Manifestations and Severity Classification

Clinical presentations of COVID-19 vary widely, ranging from completely asymptomatic infection to critical illness and death. The incubation period averages four to five days, though symptoms can appear up to fourteen days post-exposure.

1. Mild Illness: Presence of various signs and symptoms without shortness of breath or abnormal chest imaging.
2. Moderate Illness: Evidence of lower respiratory disease during clinical assessment or imaging, with an oxygen saturation ($ ext{SpO}_2$) of 94% or higher on room air.
3. Severe Illness: $ ext{SpO}_2$ dropping below 94% on room air, a respiratory rate greater than 30 breaths per minute, or lung infiltrates exceeding 50%.
4. Critical Illness: Respiratory failure, septic shock, or multiple organ dysfunction syndrome requiring intensive care support.

Diagnostic Evaluation and Laboratory Findings

Accurate diagnosis and ongoing monitoring require a combination of molecular testing and hematological biomarkers.

• RT-PCR Assay: The gold standard molecular test detecting viral RNA from nasopharyngeal or oropharyngeal swabs.
• Rapid Antigen Tests: Faster point-of-care tests that detect specific viral proteins, useful for quick screening though less sensitive than PCR.
• Complete Blood Count: Often reveals lymphopenia (low lymphocyte count) as a hallmark of viral suppression of the immune system.
• Inflammatory Markers: Elevated C-reactive protein (CRP), ferritin, and D-dimer indicate systemic inflammation and heightened risk for thrombotic complications.

Nursing Assessment and Monitoring

Continuous surveillance is vital to catch clinical deterioration early, especially during the second week of illness when hyperinflammation often peaks. Nurses must prioritize regular respiratory assessments, tracking work of breathing, use of accessory muscles, and baseline neurological status.

Pulse oximetry monitoring should be continuous or performed at frequent, scheduled intervals. Nurses should watch closely for silent hypoxia, a dangerous phenomenon where patients exhibit dangerously low blood oxygen levels without feeling short of breath or showing obvious distress. Documenting trend data on vital signs allows the multidisciplinary team to intervene before catastrophic respiratory collapse occurs.

Medical and Pharmacological Management

Pharmacotherapy for COVID-19 targets either viral replication or the overactive host immune response. Early in the disease course, antiviral medications are most effective.

Nurses must monitor renal function before and during antiviral therapy and watch for secondary infections when administering high-dose steroids.

Respiratory Support and Oxygen Therapy

Managing hypoxemia requires a stepped approach to oxygen delivery. Starting with standard nasal cannulas, clinicians escalate support based on patient response.

• High-Flow Nasal Cannula (HFNC): Delivers heated and humidified oxygen at high flow rates, washing out dead space and reducing the work of breathing.
• Non-Invasive Ventilation (NIV): Continuous Positive Airway Pressure (CPAP) or Bi-level Positive Airway Pressure (BiPAP) applied via a tight-fitting mask.
• Prone Positioning: Placing conscious or ventilated patients on their stomach improves ventilation-perfusion matching by recruiting dorsal lung units.
• Mechanical Ventilation: Reserved for patients with refractory respiratory failure, requiring strict management of lung-protective ventilation settings.

Potential Complications and Long COVID

While many individuals recover fully within weeks, others experience acute complications or persistent symptoms known as Long COVID or post-acute sequelae of SARS-CoV-2 (PASC).

Acute complications include pulmonary embolism, stroke, secondary bacterial pneumonia, acute kidney injury, and cardiac arrhythmias. Long COVID is characterized by symptoms lasting longer than twelve weeks that cannot be explained by an alternative diagnosis.

Common long COVID manifestations include chronic fatigue, brain fog, shortness of breath, joint pain, and sleep disturbances. Nurses play a crucial role in validating these chronic symptoms, providing rehabilitation referrals, and supporting patients through prolonged physical and psychological recovery.

Patient Education and Public Health Prevention

Public health strategies remain the cornerstone of controlling community transmission and protecting vulnerable populations. Nurses serve as frontline educators, dispelling myths and promoting evidence-based protective measures.

Core prevention messages include:

• Vaccination: Receiving primary series and recommended booster doses to dramatically reduce severe disease, hospitalization, and death.
• Ventilation: Improving indoor air exchange by opening windows or using air filtration systems in crowded spaces.
• Hygiene Practices: Frequent handwashing with soap and water or using alcohol-based hand sanitizer.
• Symptom Isolation: Staying home and wearing a well-fitting mask when testing positive or experiencing respiratory symptoms.